Nintedanib for the Prevention of Radiation Pneumonia in Unresectable NSCLC

Clinical trial NCT06570317 · RECRUITING

Trial details

NCT number: NCT06570317
Sponsor: Second Hospital of Shanxi Medical University
Status: RECRUITING
Study type: OBSERVATIONAL

NSCLC Nintedanib Radiation Pneumonitis

Start date: 2024-08-24
Primary completion: 2026-05-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.